about
Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatmentMutant p53 Amplifies Epidermal Growth Factor Receptor Family Signaling to Promote Mammary Tumorigenesis.The TCA cycle transferase DLST is important for MYC-mediated leukemogenesis.ErbB2 inhibition by lapatinib promotes degradation of mutant p53 protein in cancer cells.A gain-of-function mutant p53-HSF1 feed forward circuit governs adaptation of cancer cells to proteotoxic stress.CK2 inhibitor CX-4945 destabilizes NOTCH1 and synergizes with JQ1 against human T-acute lymphoblastic leukemic cells.Detection of Experimental and Clinical Immune Complexes by Measuring SHIP-1 Recruitment to the Inhibitory FcγRIIB.
P50
Q35862613-5547D4C3-87E5-4B15-A32C-D8BADCFB2BADQ36775403-306FD29A-361F-461A-9384-3F821F83ED50Q36957835-96B4DF14-44C9-480B-82C1-A5DE88CED410Q37701488-8F57BD58-F22B-4E68-9432-DEE7E2ECAFEDQ37726140-877E71C3-5399-4C6E-9B07-16F094E59C53Q42334357-D5DF8F3A-7B06-4A0D-A8F7-732A376A969AQ48204990-E4DD7868-382D-466B-9C25-47B08058DABD
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Dun Li
@en
Dun Li
@nl
type
label
Dun Li
@en
Dun Li
@nl
prefLabel
Dun Li
@en
Dun Li
@nl
P31
P496
0000-0001-6789-0763